Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Barclays Maintains Overweight on Cigna Group, Lowers Price Target to $300

Author: Benzinga Newsdesk | November 03, 2025 09:30am
Barclays analyst Andrew Mok maintains Cigna Group (NYSE:CI) with a Overweight and lowers the price target from $383 to $300.

Posted In: CI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist